|
|
Volumn 107, Issue 7, 2015, Pages
|
|
NCI-MATCH launch highlights new trial design in precision-medicine era
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
DNA;
CLINICAL TRIAL (TOPIC);
DNA SEQUENCE;
GENETIC SCREENING;
GENETICS;
HUMAN;
MASS SCREENING;
METHODOLOGY;
MOLECULARLY TARGETED THERAPY;
MUTATION;
NATIONAL HEALTH ORGANIZATION;
NEOPLASMS;
PERSONALIZED MEDICINE;
PROCEDURES;
STANDARDS;
TRENDS;
UNITED STATES;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS AS TOPIC;
DNA, NEOPLASM;
GENETIC TESTING;
HUMANS;
MASS SCREENING;
MOLECULAR TARGETED THERAPY;
MUTATION;
NATIONAL CANCER INSTITUTE (U.S.);
NEOPLASMS;
PRECISION MEDICINE;
RESEARCH DESIGN;
SEQUENCE ANALYSIS, DNA;
UNITED STATES;
|
|
EID: 84952875868
PISSN: None
EISSN: 14602105
Source Type: Journal
DOI: 10.1093/jnci/djv193 Document Type: Note |
|
Times cited : (98)
|
|
References (0)
|